Codice QR

Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion

Background: EGFR and ERBB2 exon 20 insertion (Ex20ins) account for a small fraction of patients with EGFR mutations. The efficacy of immune checkpoint inhibitors (ICIs) for these patients was still controversial. Methods: This retrospective study enrolled lung cancer patients harboring either EGFR o...

Descrizione completa

Salvato in:
Autori principali: Yue Zheng, Yang Fu, Yueyun Chen, Qing Li, Ting Liu, Zhenyu Ding
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2023-11-01
Serie:Current Oncology
Soggetti:
EGFR
ERBB2
exon 20 insertion
immunochemotherapy
lung cancer
Accesso online:https://www.mdpi.com/1718-7729/30/11/721
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi